Cambridge, MA, United States of America

Steven Christopher Gilman

USPTO Granted Patents = 11 


 

Average Co-Inventor Count = 4.5

ph-index = 8

Forward Citations = 473(Granted Patents)


Location History:

  • Cresco, PA (US) (1991)
  • Old Lyme, CT (US) (2004 - 2006)
  • Cambridge, MA (US) (2008 - 2018)

Company Filing History:


Years Active: 1991-2018

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Steven Christopher Gilman: Innovator in Monoclonal Antibodies

Introduction

Steven Christopher Gilman is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of human monoclonal antibodies. With a total of 11 patents to his name, Gilman's work has had a profound impact on medical research and therapeutic applications.

Latest Patents

One of Gilman's latest patents involves the creation of fully human monoclonal antibodies against human cytotoxic T-lymphocyte antigen 4 (CTLA-4). This invention provides nucleotide sequences encoding and amino acid sequences comprising heavy and light chain immunoglobulin molecules. Specifically, it includes contiguous heavy and light chain sequences spanning the complementarity determining regions (CDRs), particularly from within FR1 and/or CDR1 through CDR3 and/or within FR4. The patent further details antibodies that possess similar binding properties and functionality as those disclosed.

Career Highlights

Throughout his career, Steven Gilman has worked with leading companies in the biotechnology sector, including Pfizer Corporation and Amgen Fremont Inc. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the field of immunology.

Collaborations

Some of his notable coworkers include Douglas Charles Hanson and Mark Joseph Neveu. Their collaborative efforts have further advanced the research and development of innovative therapeutic solutions.

Conclusion

Steven Christopher Gilman is a distinguished inventor whose work in monoclonal antibodies has significantly influenced the field of biotechnology. His patents and collaborations continue to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…